Position in GSK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$19,709,448
-$1,162,858 QoQ
Shares Held
375,991
-0.6% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#74
of 1,033 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cetera Investment Advisers holds $1,560,895,629 across 16 Drug Manufacturers - General names. GSK ranks #11 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
366,026 | $439,022,601 | |
| 2 | JNJ |
Johnson & Johnson
|
1,094,399 | $277,944,514 | |
| 3 | ABBV |
AbbVie Inc.
|
990,692 | $249,297,734 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,229,081 | $157,936,908 | |
| 5 | AMGN |
Amgen Inc
|
333,544 | $120,782,953 | |
| 6 | PFE |
Pfizer Inc
|
3,183,708 | $76,663,688 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
413,202 | $52,203,940 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
883,910 | $50,930,894 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,709,448 | 375,991 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $20,872,306 | 378,190 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $22,678,106 | 462,441 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $20,724,655 | 480,182 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $14,148,710 | 368,456 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $11,100,830 | 286,547 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $8,881,098 | 262,599 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $11,133,177 | 272,338 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $10,830,935 | 281,323 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $12,053,672 | 281,168 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $2,601,500 | 70,197 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,146,028 | 86,787 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,719,260 | 76,298 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,683,265 | 75,415 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,249,381 | 64,012 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,452,694 | 49,361 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,472,166 | 57,904 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,691,205 | 62,991 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,661,720 | 61,538 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,598,629 | 42,657 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,586,745 | 40,628 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,252,259 | 35,774 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,227,140 | 33,999 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $475,827 | 12,889 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $538,812 | 13,468 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $460,406 | 12,389 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||